olopatadine hydrochloride - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
RYALTRIS olopatadine 600 microgram/actuation and mometasone furoate 25 microgram/actuation nasal spray bottle
AUST R: 473905
Active ingredients:
mometasone furoate monohydrate
olopatadine hydrochloride

Dosage form:
Spray, nasal

Sponsor:
Seqirus Pty Ltd

Phone:
1800 642 865

From
30 Nov 2026
to
04 Jan 2027

Shortage status:
Anticipated

Availability:
Available

Reason:
Unexpected increase in consumer demand

Management action:
The sponsor is working to expedite the next shipment. Alternative presentation is available.